Live Breaking News & Updates on Taro pharmaceutical

Stay informed with the latest breaking news from Taro pharmaceutical on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Taro pharmaceutical and stay connected to the pulse of your community

StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research note issued to investors on Saturday. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price target for the company. […]

Canada , United-states , Israel , Taro-pharmaceutical-industries , Crystalline-management-inc , Harvest-management , Institutional-trading-of-taro-pharmaceutical-industries , Penderfund-capital-management-ltd , News-ratings-for-taro-pharmaceutical-industries-daily , Taro-pharmaceutical-industries-stock , Taro-pharmaceutical-industries-ltd

Iran-Israel conflict: India Inc closely watches developments to ensure safety of employees in West Asia

Sun Pharma, which operates in Israel through its subsidiary Taro Pharmaceutical, is actively monitoring the situation in the country and is taking all necessary steps to ensure safety and wellbeing of employees and their families, a company spokesperson said in an email response to ET.

India , Gaza , Israel-general- , Israel , Australia , Lucknow , Uttar-pradesh , Iran , Israeli , Kartik-narayan , Sun-pharma , India-inc

Israel conflict: Staff safety on India Inc radar in troubled West Asia

Indian companies are closely monitoring the safety of employees in Israel, a West Asian innovation hub, amid the intensifying Israel-Iran conflict. Sun Pharma, with a presence in Israel through its subsidiary Taro Pharmaceutical, is taking steps to ensure the safety and wellbeing of its employees and their families.

Iran , Israel , India , Israeli , Kartik-narayan , Sun-pharma , Infosys , Teamlease-services , Wipro , West-asian , Taro-pharmaceutical , Tech-mahindra

Middle East crisis escalation may hurt pharma exports

The conflict in the Middle East could impact Indian pharma exports to the MENA region, potentially leading to supply chain disruptions and shortages of essential drugs. Key Indian pharma companies like Sun Pharma, Dr Reddy's, and Lupin may be affected.

India , Syria , Yemen , Qatar , Iran , Saudi-arabia , Iraq , Gaza , Israel-general- , Israel , Egypt , Bahrain

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report published on Sunday morning. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut shares of Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. […]

Canada , Israel , United-states , Taro-pharmaceutical-industries-price-performance , Taro-pharmaceutical-industries-ltd , Allspring-global-investments-holdings , Invesco-ltd , Taro-pharmaceutical-industries-company-profile , Connor-clark-lunn-investment-management-ltd , News-ratings-for-taro-pharmaceutical-industries-daily , Institutional-trading-of-taro-pharmaceutical-industries

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated by Analysts at StockNews.com

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated by Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Israel , Canada , Switzerland , Swiss , American , Taro-pharmaceutical-industries-stock-performance , Taro-pharmaceutical-industries-ltd , Us-bancorp , Institutional-trading-of-taro-pharmaceutical-industries , Taro-pharmaceutical-industries-company-profile

Sun Pharma issues recall of gout drug due to microbial contamination

Sun Pharma issues recall of gout drug due to microbial contamination
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

India , Sun-pharma-dadra , Sun-pharma , Taro-pharmaceutical , Israel-based-taro ,

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Sees Large Decline in Short Interest

Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 79,900 shares, a decline of 18.9% from the January 15th total of 98,500 shares. Approximately 1.0% of the shares of the company […]

Canada , Israel , United-states , Taro-pharmaceutical-industries-stock , Norges-bank , Institutional-trading-of-taro-pharmaceutical-industries , Crystalline-management-inc , News-ratings-for-taro-pharmaceutical-industries-daily , Taro-pharmaceutical-industries-ltd , Taro-pharmaceutical-industries , Get-free-report

Sun Pharma Q3 results today: What to expect from India's top drug maker?

Sun Pharmaceutical Industries is set to release its Q3 results, with expected moderate earnings growth. Analysts will monitor factors including US business growth, Taro Pharmaceutical's performance, margin trajectory, planned product launches, and R&D investments. Estimated growth in net profit, revenue, and operating profit is also anticipated. The company is expected to see a rise in US revenue, driven by specialty sales. Growth in domestic formulations is projected, and R&D spend will be closely monitored.

Mohali , Madhya-pradesh , India , Sun-pharmaceutical-industries , Taro-pharmaceutical , Institutional-equities , Sun-pharma-q3-results , Sun-pharma-q3-net-profit , Growth , Net-interest-income , Sun-pharma-q3-earnings

Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...

Justin-kuehn , Restaurant-brands-international , Carrols-restaurant-group , Innovations-inc , Taro-pharmaceutical-industries , Nasdaq , Ansys , Ansys-inc , Taro-pharmaceutical-industries-ltd , Carrols-restaurant-group-inc , Synopsys , Sun-pharmaceutical-industries